Evidence map›Paper›PMID 39948670›Full record

ArticleJournal of biomedical science2025

miR-200c inhibition and catalase accelerate diabetic wound healing.

Marco D'Agostino, Sara Sileno, Daniela Lulli, Naomi De Luca, Claudia Scarponi, Massimo Teson, Alessio Torcinaro, Francesca De Santa, Corrado Cirielli, Sergio Furgiuele and 7 more

Abstract read
In one paragraph

Article in Journal of biomedical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. The Wound-Heart Axis: Can Chronic Wounds Contribute to Cardiac Dysfunction?International journal of molecular sciences · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Marco D'AgostinoMolecular Regenerative Medicine Laboratory, Istituto Dermopatico dell'Immacolata (IDI-IRCCS), Rome, Italy.
Sara SilenoMolecular Regenerative Medicine Laboratory, Istituto Dermopatico dell'Immacolata (IDI-IRCCS), Rome, Italy.
Daniela LulliExperimental Immunology Laboratory, Istituto Dermopatico dell'Immacolata (IDI-IRCCS), Rome, Italy.
Naomi De LucaLaboratory of Molecular Biology, Istituto Dermopatico dell'Immacolata (IDI-IRCCS), Rome, Italy.
Claudia ScarponiExperimental Immunology Laboratory, Istituto Dermopatico dell'Immacolata (IDI-IRCCS), Rome, Italy.
Massimo TesonLaboratory of Molecular Biology, Istituto Dermopatico dell'Immacolata (IDI-IRCCS), Rome, Italy.
Alessio TorcinaroInstitute of Biochemistry and Cell Biology (IBBC), National Research Council of Italy (CNR), Rome, Italy.
Francesca De SantaInstitute of Biochemistry and Cell Biology (IBBC), National Research Council of Italy (CNR), Rome, Italy.
Corrado CirielliUnit of Vascular Surgery, Istituto Dermopatico dell'Immacolata (IDI-IRCCS), Rome, Italy.
Sergio FurgiueleUnit of Vascular and Endovascular Surgery, High Speciality Hospital "Mediterranea", Naples, Italy.
Chris H MorrellLaboratory of Cardiovascular Science, National Institute on Aging (NIA), National Institutes of Health (NIH), Baltimore, MD, USA.
Elena DellambraLaboratory of Molecular Biology, Istituto Dermopatico dell'Immacolata (IDI-IRCCS), Rome, Italy.
Teresa OdorisioLaboratory of Molecular Biology, Istituto Dermopatico dell'Immacolata (IDI-IRCCS), Rome, Italy.
Edward G LakattaLaboratory of Cardiovascular Science, National Institute on Aging (NIA), National Institutes of Health (NIH), Baltimore, MD, USA.
Daniele AvitabileIdi Farmaceutici S.r.l., Pomezia, Italy.
M C Capogrossi *Laboratory of Cardiovascular Science, National Institute on Aging (NIA), National Institutes of Health (NIH), Baltimore, MD, USA.
Alessandra Magenta *Molecular Regenerative Medicine Laboratory, Istituto Dermopatico dell'Immacolata (IDI-IRCCS), Rome, Italy. alessandra.magenta@ift.cnr.it.ORCID http://orcid.org/0000-0002-9054-337X

Funding

Ministero della Salute RC2023Ministero della Salute RF02362708Regione Lazio POR A0375-2020- 36572
6 · The paper itself

Abstract

backgroundReactive oxygen species (ROS) are increased in diabetic conditions and play a causal role in diabetic foot ulcers (DFU). We previously showed that ROS up-regulate miR-200c expression, that in turns causes apoptosis, senescence, ROS upregulation and nitric oxide decrease, leading to endothelial disfunction.

methodsThe aim of this study is to dissect miR-200c role in DFU and to explore the potential role of anti-miR-200c and antioxidant catalase (CAT) in promoting wound healing (WH). miR-200c inhibition and CAT treatment were performed either in immortalized keratinocytes (HaCaT) or in primary fibroblasts (FBs) and keratinocytes (KCs) deriving from diabetic patients (pts) undergoing amputations. Primary cells deriving from pts undergoing saphenectomies were used as controls. The miR-200c blockade was performed either via lentiviral particles bearing an anti-miR-200c sequence or locked nucleic acid (LNA) anti-miR-200c oligos. Equine CAT was administered on cell medium. The WH assay was performed in vivo on diabetic (db/db) mice by a topical treatment with CAT and LNA anti-miR-200c on wounds dissolved in a Pluronic gel mixture, administered every three days.

resultsWe found that miR-200c levels were increased by different stimuli known to induce ROS, such as ultraviolet radiation (UV), hydrogen peroxide (H

conclusionsAnti-miR-200c and CAT could be considered a novel treatment for DFU and, possibly, for other types of non-diabetic skin ulcers.

Indexed as

CatalaseDiabetic FootMicroRNAsWound HealingAnimalsDiabetes Mellitus, ExperimentalHumansMaleMiceCatalaseMicroRNAsMIRN200 microRNA, humanMirn200 microRNA, mouseApoptosisCatalaseDiabetic foot ulcersMicroRNAsReactive oxygen speciesSkin

Identifiers

PMID39948670
PMCPMC11827459

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.